Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!
  Get the Manual of Investments on Amazon!
Subscribe

FINANCE
Velocity Financial Releases 10-K Report
2026-03-12
FINANCE
CION Investment Corp Reports 7.4% NAV Decrease
2026-03-12
BBW
Build-A-Bear Workshop Announces CEO Succession
2026-03-12
GYRE
UNITED STATES
HEALTH CARE
Gyre Therapeutics Sees 10% Revenue Growth in 2025
Gyre Therapeutics has reported its financial results for the fourth quarter and full year 2025, along with providing a business update. The company's full-year 2025 revenue increased by 10% year-over-year to $116.6 million, falling within the revised guidance range. Looking ahead, the company has given revenue guidance for full year 2026 in the range of $100.5 to $111.0 million, representing a potential decline compared to 2025. For the three months ended December 31, 2025, the company...
Thursday, March 12
Market Inference Newsletter
TOP STORIES
ProFrac (ACDC) Reports Decreased Revenue and Increased Losses
Profrac Holding Corp. (NASDAQ: ACDC) has released its financial and operational results for the full year and fourth quarter of 2025, revealing...
Indivior Pharmaceuticals Announces $400M Convertible Notes Offering
Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) has announced its plan to offer $400,000,000 aggregate principal amount of convertible senior notes...
Dick's Sporting Goods Reports Strong Growth in Q4 and Full Year 2025
Dick's Sporting Goods, Inc. has reported its fourth quarter and full year 2025 results, showing significant growth and performance. The company...
GPGI Reports Strong Q4 Growth & Debt Refinancing
GPGI Inc. (NYSE: GPGI) has reported strong fourth-quarter results for 2025, with significant growth across key financial metrics. The company's...

Market Trends

RHLD
FINANCE
UNITED STATES
Resolute Holdings Reports 2025 Financial Results
Resolute Holdings Reports Fourth Quarter and Full Year 2025 Results Resolute Holdings, an operating management company providing services to the...
Thursday, March 12
FSUN and FFWM Merger Approved by Federal Reserve
FINANCE
FFWM Receives Regulatory Approval for Merger
FINANCE
Aveanna Healthcare to Acquire Family First Homecare
HEALTH CARE
G-III Apparel Group Reports $2.96B in Net Sales for Fiscal 2026
GIII
Integer Holdings Corporation Appoints Two Independent Directors
ITGR
Angi Appoints Julie Hoarau as CFO
ANGI
MBX Biosciences Focuses on Precision Peptide Therapies
MBX
ENERGY
CLMT
UNITED STATES
Calumet Specialty Products Partners, L.P. Enters Tenth Amendment to Credit Agreement
In the latest press release, Calumet Specialty Products Partners, L.P. has announced its...
Thursday, March 12
NXP Semiconductors announces $1.014 dividend
TECHNOLOGY
Halozyme appoints David Ramsay as interim CFO
HEALTH CARE
L3Harris Technologies Appoints Sam Mehta as President
INDUSTRIALS
Pulse Biosciences Enrolls Patients in PTM Study
HEALTH CARE
Palantir Partners with Ondas for AI ISR Solutions
UNITED STATES
Liberty Global to Present at Global Connectivity Leaders Conference
LBTYA
Archer-Daniels-Midland Co Appoints Former LyondellBasell Executive to Board
UNITED STATES
Popular
Hallador Energy secures $120M credit agreement, shares rise 4.01%
Blackline, Inc. (BL) Announces Board Changes and Strong Financial Growth
Global Indemnity 2025 Financial Report Shows 2.3% Premium Increase
AeroVironment Inc – Shares Up 3.77%
Pangaea Logistics Reports Strong Q4 Results
Proxy Firms Back Contango ORE Acquisition
News Corp Plans $1 Billion Stock Buyback
Preminium Access

In Focus

Wednesday, March 11
ORCL's Cloud Revenues Surge, Driving Stock Up 0.65%
Wednesday, March 11
Cintas to Acquire UniFirst for $5.5 Billion
Wednesday, March 11
Target Hospitality Corp. Reports $37.1 Million Net Loss in 2025
Wednesday, March 11
Flutter Entertainment Launches $250M Share Repurchase Program
Wednesday, March 11
Bread Financial Holdings Reports Improved Credit Metrics
Wednesday, March 11
Serve Robotics (SERV) Reports 400% Revenue Surge
Wednesday, March 11
Smith Douglas Homes (SDHC) Reports Decline in Financial Performance
Wednesday, March 11
Crispr Therapeutics Announces $350M Convertible Notes Offering